Advertisement

Topics

Alfa Aesar Company Profile

06:37 EST 25th November 2017 | BioPortfolio

Since 1963, scientists have relied on Alfa Aesar to supply high purity raw materials for a variety of research and development applications. Today, we are a recognized leader in the manufacture and supply of fine chemicals, metals and materials in sizes from gram-scale catalog items to semi-bulk and bulk production quantities. With over 27,000 standard catalog and bulk products in stock and the custom manufacturing capabilities to supply many more specialized items, we are a one-stop source for research chemicals, metals and materials.
Research chemicals for a broad range of applications
Our product line consists of a comprehensive range of inorganic, organic and organometallic compounds; pure metals and elements; precious metal compounds and catalysts; rare earths; analytical products; and select laboratory equipment. Backed by the global manufacturing network of Johnson Matthey and other key partnerships, we offer customers the highest quality and purity in fine chemical products. We are accustomed to supplying R and D laboratories in the pharmaceutical industry and the electronics industry, as well as academic institutions and many others. With most catalog items in stock for same-day shipment, and a friendly and knowledgeable staff, we provide customers with an unsurpassed level of service.

Location

26 Parkridge Road
Ward Hill
Massachusetts
1835
United States of America

Contact

Phone: 1-978-521-6300
Fax: 1-978-521-6350
Email: info@alfa.com


News Articles [101 Associated News Articles listed on BioPortfolio]

Research Chemicals Leader Alfa Aesar to be acquired by Thermo Fisher Scientific

Thermo Fisher Scientific have signed a definitive agreement to acquire Alfa Aesar, a leading global manufacturer of research chemicals, for £256 million (approximately $405 million USD) in cash. Alfa...

Human medicines European public assessment report (EPAR): Epoetin Alfa Hexal, epoetin alfa, Revision: 18, Authorised

FDA rejects Pfizer’s epoetin alfa biosimilar

US pharma giant Pfizer announced on 22 June 2017 that the US Food and Drug Administration (FDA) had rejected its application for approval of its epoetin alfa biosimilar.

FDA Approves Mepsevii (vestronidase alfa) for Mucopolysaccharidosis Type VII

November 15, 2017 -- The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolys...

Global and Asia 2Methoxy2Methylheptane CAS 76589167 Market Status and Future Forecast 20132023 [Report Updated: 10112017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Hospira to pay Amgen US$70 million for epoetin alfa patent infringement

US-based injectables specialist Hospira has been ordered to pay Biotech giant Amgen US$70 million in damages regarding a patent on Amgen’s anaemia blockbuster Epogen (epoetin alfa).

Global and Asia Alcohol Dehydrogenase Market Status and Future Forecast 20132023 [Report Updated: 18112017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Global 2Methoxy2Methylheptane CAS 76589167 Market Data Survey Report 2025 [Report Updated: 10112017] Prices from USD $1500

SummaryThe global 2Methoxy2Methylheptane CAS 76589167 market will reach Volume Million USD in 2017 with CAGR xx% 20182025. The main contents of the report including:Global market size and forecastRegi...

Drugs and Medications [57 Associated Drugs and Medications listed on BioPortfolio]

Ribavirin [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets Initial U.S. Approval: 200...

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribasphere ribapak [Three Rivers Pharmaceuticals, LLC]

These highlights do not include all the information needed to use Ribasphere (ribavirin, USP) safely and effectively. See full prescribing information for Ribasphere (ribavirin, USP). Ribasphere (riba...

PubMed Articles [36 Associated PubMed Articles listed on BioPortfolio]

Asymmetric Synthesis of alfa,alfa-Disubstituted Allylic Amines via Pd-Catalyzed Allylic Substitution.

The first asymmetric synthesis of important alfa,alfa-disubstituted N-alkyl allyl amine scaffolds via allylic substitution is reported. This approach is based on palladium catalysis and features ample...

Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: A randomized controlled trial.

To compare the efficacy and safety of poractant alfa and bovine lipid extract surfactant in preterm infants.

Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation.

Extracellular histones are reported to increase thrombin generation in the plasma and induce endothelial cell death in vitro. These effects of histones were suggested to involve histone-induced inhibi...

Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin alfa (GGF2) Clinical Trials.

Cimaglermin alfa (GGF2) is a recombinant human protein growth factor in development for heart failure. Phase 1 trials were suspended when 2 cimaglermin alfa-treated subjects experienced concomitant el...

An Open-label, Single-Dose, Pharmacokinetic Study of Factor VIII Activity After Administration of Moroctocog Alfa (AF-CC) in Male Chinese Patients With Hemophilia A.

Hemophilia A represents up to 80% of all hemophilia cases in China. In patients with this condition, bleeding can be prevented and controlled by administering clotting factor VIII (FVIII). Since their...

Clinical Trials [866 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Reduction and Viral Safety of IFN Alfa-2b XL + Ribavirin Versus PEG IFN Alfa-2b + Ribavirin in Patients With Chronic Hepatitis C Genotype 1

The purpose of this study is to confirm if IFN alfa-2b XL has a better antiviral activity and tolerability as compared with current marketed reference, while combined with ribavirin, in a ...

Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

The purpose of this study is to evaluate the cost-effectiveness of epoetin alfa compared with darbepoetin alfa in the treatment of anemia in adults receiving chemotherapy for cancer. Epoe...

PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients

The purpose of this study is to demonstrate that once every-2-weeks and once every-4-weeks treatment with epoetin alfa, a drug that increases red blood cell production, in patients with an...

Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders

In an opened randomized study of women undergoing in vitro fertilization with expected suboptimal response to controlled ovarian stimulation (Poseidon Group 2b) investigators will examine ...

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

RATIONALE: Epoetin alfa and darbepoetin alfa may cause the body to make more red blood cells. They are used to treat anemia caused by chemotherapy in patients with cancer. PURPOSE: This r...

Companies [25 Associated Companies listed on BioPortfolio]

Alfa Aesar

Since 1963, scientists have relied on Alfa Aesar to supply high purity raw materials for a variety of research and development applications. Today, we are a recognized leader in the manufacture and su...

Assisted Living Federation of America (ALFA)

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors an...

Alfa Laval

Alfa Laval is a leading global provider of specialized products and engineered solutions. Our equipment, systems and services are dedicated to helping customers to optimize the performance of their pr...

Assisted Living Federation of America

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors and families they serve...

Alfa Wassermann, Inc

Under one name or another, Alfa Wassermann, Inc. has provided high quality products and services to the health care community since 1960. Our parent company, the Alfa Wassermann Group, headquartered i...

More Information about "Alfa Aesar" on BioPortfolio

We have published hundreds of Alfa Aesar news stories on BioPortfolio along with dozens of Alfa Aesar Clinical Trials and PubMed Articles about Alfa Aesar for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alfa Aesar Companies in our database. You can also find out about relevant Alfa Aesar Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record